{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT03555448",
            "orgStudyIdInfo": {
                "id": "201803162"
            },
            "organization": {
                "fullName": "Washington University School of Medicine",
                "class": "OTHER"
            },
            "briefTitle": "Once Daily Immunosuppression Regimen",
            "officialTitle": "Once a Day Immunosuppression Regimen: Outcomes and Compliance",
            "therapeuticArea": [
                "Nephrology and Renal Diseases"
            ],
            "study": "once-daily-immunosuppression-regimen"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-12",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2018-06-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2018-05-17",
            "studyFirstSubmitQcDate": "2018-05-31",
            "studyFirstPostDateStruct": {
                "date": "2018-06-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-12-30",
            "lastUpdatePostDateStruct": {
                "date": "2023-01-04",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Washington University School of Medicine",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Veloxis Pharmaceuticals",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this research study is to determine whether an immunosuppressive maintenance regimen of Envarsus/azathioprine compared to a tacrolimus/ mycophenolic acid regimen is associated with better compliance, tolerability, and lower biopsy proven rejection."
        },
        "conditionsModule": {
            "conditions": [
                "Kidney Transplant; Complications"
            ],
            "keywords": [
                "Immunosuppression"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Once daily regimen",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Once daily medication regimen (Envarsus and azathioprine)",
                    "interventionNames": [
                        "Drug: Once daily immunosuppression regimen"
                    ]
                },
                {
                    "label": "Twice daily regimen",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Twice daily medication regimen (Tacrolimus and mycophenolic acid)",
                    "interventionNames": [
                        "Drug: Twice daily immunosuppression regimen"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Once daily immunosuppression regimen",
                    "description": "Intervention focuses on the type of regimen, in this case the intervention arm will receive a once daily regimen for immunosuppression compared to the twice daily regimen.",
                    "armGroupLabels": [
                        "Once daily regimen"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Twice daily immunosuppression regimen",
                    "description": "This is the arm which we are designating the standard, which will be the comparison to the active drug arm.",
                    "armGroupLabels": [
                        "Twice daily regimen"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in Compliance and tolerability of medication regimen at 3 and 12 months",
                    "description": "BAASIS Survey",
                    "timeFrame": "3 months and 12 months post transplant"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in Self-recorded Compliance and tolerability of medication regimen at 3 and 12 months",
                    "description": "Pill Manager (personal medication record keeping for those who participants who choose to use this method of recording their self-administered medication)",
                    "timeFrame": "3 months and 12 months post transplant"
                },
                {
                    "measure": "Composite endpoint measurement",
                    "description": "Incidence of Biopsy proven Acute Rejection, graft loss, death, Lost to follow-up at 12 months.",
                    "timeFrame": "12 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \\>/= 18 years old\n* Kidney transplant recipient\n* Thymoglobulin induction\n\nExclusion Criteria:\n\n* Non-renal organ transplant\n* Combined organ transplant\n* Inability to receive Envarsus after transplant\n* Discharged to acute care facility after transplant",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Rowena Delos Santos, MD",
                    "role": "CONTACT",
                    "phone": "314-362-8351",
                    "email": "delossantos@wustl.edu"
                },
                {
                    "name": "Tarek Alhamad, MD",
                    "role": "CONTACT",
                    "phone": "314-362-8351",
                    "email": "talhamad@wustl.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Rowena Delos Santos",
                    "affiliation": "Washington University School of Medicine",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Washington University",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rowena Delos Santos, MD",
                            "role": "CONTACT",
                            "phone": "314-362-8351"
                        },
                        {
                            "name": "Tarek Alhamad, MD",
                            "role": "CONTACT",
                            "phone": "314-362-8351"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "25278376",
                    "type": "BACKGROUND",
                    "citation": "Budde K, Bunnapradist S, Grinyo JM, Ciechanowski K, Denny JE, Silva HT, Rostaing L; Envarsus study group. Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial. Am J Transplant. 2014 Dec;14(12):2796-806. doi: 10.1111/ajt.12955. Epub 2014 Oct 2."
                },
                {
                    "pmid": "23279614",
                    "type": "BACKGROUND",
                    "citation": "Bunnapradist S, Ciechanowski K, West-Thielke P, Mulgaonkar S, Rostaing L, Vasudev B, Budde K; MELT investigators. Conversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trial. Am J Transplant. 2013 Mar;13(3):760-9. doi: 10.1111/ajt.12035. Epub 2012 Dec 21."
                },
                {
                    "pmid": "26372087",
                    "type": "BACKGROUND",
                    "citation": "Jamieson NJ, Hanson CS, Josephson MA, Gordon EJ, Craig JC, Halleck F, Budde K, Tong A. Motivations, Challenges, and Attitudes to Self-management in Kidney Transplant Recipients: A Systematic Review of Qualitative Studies. Am J Kidney Dis. 2016 Mar;67(3):461-78. doi: 10.1053/j.ajkd.2015.07.030. Epub 2015 Sep 11."
                },
                {
                    "pmid": "22898791",
                    "type": "BACKGROUND",
                    "citation": "Laliberte F, Nelson WW, Lefebvre P, Schein JR, Rondeau-Leclaire J, Duh MS. Impact of daily dosing frequency on adherence to chronic medications among nonvalvular atrial fibrillation patients. Adv Ther. 2012 Aug;29(8):675-90. doi: 10.1007/s12325-012-0040-x. Epub 2012 Aug 15."
                },
                {
                    "pmid": "26717860",
                    "type": "BACKGROUND",
                    "citation": "Rostaing L, Bunnapradist S, Grinyo JM, Ciechanowski K, Denny JE, Silva HT Jr, Budde K; Envarsus Study Group. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial. Am J Kidney Dis. 2016 Apr;67(4):648-59. doi: 10.1053/j.ajkd.2015.10.024. Epub 2015 Dec 22."
                },
                {
                    "pmid": "25694538",
                    "type": "BACKGROUND",
                    "citation": "Vrijens B, Heidbuchel H. Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence. Europace. 2015 Apr;17(4):514-23. doi: 10.1093/europace/euu311. Epub 2015 Feb 17."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M12128",
                    "name": "Mycophenolic Acid",
                    "relevance": "LOW"
                },
                {
                    "id": "M18950",
                    "name": "Tacrolimus",
                    "relevance": "LOW"
                },
                {
                    "id": "M4678",
                    "name": "Azathioprine",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                },
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                }
            ]
        }
    },
    "hasResults": false
}